The Week’s Best Longreads for October 26, 2013
The Daily Beast picks the best journalism from around the web this week. By David Sessions.


Obama’s Uncertain Path on SyriaMark Mazzetti, Robert F. Worth, and Michael R. Gordon, The New York TimesA riveting play-by-play of the administration’s stumbling, halting move toward—and then away from—an intervention in Syria.
Dignity’s DueSamuel Moyn, The NationWhy are philosophers invoking the notion of human dignity to revitalize theories of political ethics?
The Cost of LivingStephen S. Hall, New YorkAs cancer drugs have become more expensive—in a few cases, staggeringly so—their effectiveness has often failed to rise in tandem. So some doctors are refusing to use them, asking the controversial question: Are a few extra weeks of life worth all that money? Inside an oncologists’ revolt.
Stop KonyElizabeth Rubin, The New Yorker OnlineHow a Texas philanthropist funded the hunt for Joseph Kony, the deadly leader of Uganda’s guerilla Lord’s Resistance Army.
ADVERTISEMENT
Why Can’t We All Just Get Along?Robert Wright, The AtlanticSquaring new research that suggests we’re “naturally moral” with the violence and chaos around us.
Blue Spark, Part OneNelly Reifler, The WeeklingsOn the tenth anniversary of Elliot Smith’s tragic death, a friend remembers her deep friendship with him.
Get the best of The Beast delivered right to your inbox
By clicking “SUBSCRIBE” you agree to our Terms of Use and Privacy Policy.
For more great longreads, visit our friends at Longreads.com.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.
